Artificial Intelligence Based Surgical Robots Market Size, Share - Growth Analysis Report and Forecast Trends 2026-2030

AI-based surgical robots combine mechanical platforms, high-definition visualization, and AI-driven software that supports surgeons in planning, executing, and reviewing procedures. The category is closely related to the broader surgical robotics market, which is valued significantly higher when conventional robotic-assisted systems are included. Demand is strongest in urology, gynecology, general surgery, orthopedics, and neurosurgery, with hospitals and ambulatory surgical centers serving as the primary end users.

• •Estimated 2025 valuation of about USD 8.0 billion with an 18.0% CAGR.
• •Direct AI-in-robot-assisted surgery segment projected to add roughly USD 11.3 billion in incremental value between 2025 and 2029.
• •Closely linked to the overall surgical robotics market, estimated near USD 12.5 billion in some industry assessments.

The shift toward minimally invasive surgery is the principal demand driver, as AI-enabled platforms help reduce complications, shorten recovery times, and lower the total cost of care. Continuous improvements in machine learning, computer vision, haptic feedback, and intraoperative imaging are expanding the range of procedures that can be robotically assisted. Reimbursement expansion, hospital investment in digital operating rooms, and a global shortage of specialized surgeons are accelerating adoption.

• •Rising preference for minimally invasive procedures across urology, gynecology, and oncology.
• •Advances in AI models, real-time imaging, and sensor technology broadening clinical use cases.
• •Aging populations and surgeon shortages in North America, Europe, and parts of Asia driving automation demand.

The market is commonly segmented by component (systems, instruments and accessories, services), by application (urological, gynecological, orthopedic, neurological, general surgery, and others), and by end user (hospitals, ambulatory surgical centers, specialty clinics). Regionally, North America leads on the back of strong reimbursement, early FDA clearances, and dense hospital deployment, while Europe is a mature secondary market. Asia-Pacific is the fastest-growing region, supported by large healthcare investments in China, Japan, South Korea, and India.

• •Systems account for the largest component share, with instruments, accessories, and services providing recurring revenue.
• •Urological and gynecological procedures represent the most established application segments.
• •Asia-Pacific is expanding fastest, while North America retains the largest revenue share.

What are the recent trends and outlook?

AI capabilities are moving from add-on analytics toward embedded decision support, autonomous subtasks, and intraoperative guidance tied to real-time imaging. Connectivity across operating rooms, cloud-based analytics, and tighter integration with hospital information systems are shaping procurement decisions. With double-digit annual growth expected through the late 2020s and into the 2030s, AI-based surgical robotics is set to remain one of the faster-expanding segments of medical technology.

• •Movement toward autonomous and semi-autonomous surgical functions under surgeon supervision.
• •Greater emphasis on data-driven outcomes, cloud platforms, and interoperability with electronic health records.
• •Long-term forecast points to sustained double-digit growth as indications, geographies, and AI maturity all expand.